Zurueck zur Suche

Reporte zur Charge UJ909AA

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

27Reporte angezeigt
0Todesfaelle
0Hospitalisiert
0Lebensbedrohlich
0Bleibende Schaeden
MO 4 LA 3 TX 3 IL 2 NY 2 FL 2 MS 2 SD 1 GA 1 PA 1 NC 1 OK 1

VAERS 2475595

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

schwer
Staat
IL
Alter
37,0
Geschlecht
M
Eingang
11.10.2022
Impfdatum
11.10.2022
Beginn
11.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein
Aphasia Condition aggravated Fall Muscle tightness Seizure Tremor

Symptomtext

Received Pfizer bivalent, was talking and discussing past side effects. Received flublok then stopped talking. Slumped in chair as if fainting. Intern held patient steady to avoid injury and called for backup. The patient began tensing up and shaking at this point, so pharmacist called EMS while the intern monitored the patient. He recovered and was responsive, but began to seize again once paramedics began to evaluate him.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Seizure
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
history of seizure
Andere Medikamente
After the seizure, patient stated he takes Keppra for a seizure 2 years ago, but it is not filled at our pharmacy.
Allergien
none
Vorherige Impfungen
-

VAERS 2522649

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

moderat
Staat
IL
Alter
31,0
Geschlecht
M
Eingang
04.12.2022
Impfdatum
30.10.2022
Beginn
31.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Mobility decreased Pain in extremity

Symptomtext

Patient reported to pharmacy today, 34 days after injection, stating he has had a very abnormally sore arm, cannot lift his arm above his head and assumed that was not normal to still have. He was encouraged to be checked out by his physician as soon as possible.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Mobility decreased
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2464671

GLAXOSMITHKLINE BIOLOGICALS · INFLUENZA (SEASONAL) (FLUARIX QUADRIVALENT) · Charge UJ909AA

moderat
Staat
NY
Alter
42,0
Geschlecht
F
Eingang
29.09.2022
Impfdatum
26.09.2022
Beginn
29.09.2022
Tage bis Beginn
3,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Dyspnoea Pain Pain in extremity Peripheral swelling Pruritus Swelling Swelling face

Symptomtext

Patient reported today that she took Flu vaccine on 9/26/22 and she develops swelling of arms, legs, face and stomach . In addition, she reported having body aches, whales all over her body, pain in the arms and legs and difficulty breathing. However, patient states she self administered Epi pen and took benadryl and now her symptom is improving. Denies SOB.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dyspnoea
Hospital-Tage
-
Labordaten
Recommend patient to go to ER but patient refused. None
Aktuelle Erkrankungen
Reports itchiness over whole body on 9/26/22, foot pain
Vorgeschichte
Rheumatoid arthritis, H/O renal insufficiency syndrome, nasal polyp, asthma, bipolar disorder
Andere Medikamente
acetaminophen (Tylenol Extra Strength) 500 mg tablet albuterol (PROVENTIL) 2.5 mg/3 mL nebulizer solution albuterol (PROVENTIL) 2.5 mg/3 mL nebulizer solution ascorbic acid, vitamin C, (vitamin C) 1000 MG tablet azelastine (ASTELIN) 137
Allergien
Allergies to Eggs, milk containing products, shellfish containing products, tea.
Vorherige Impfungen
-

VAERS 2556026

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
FL
Alter
62,0
Geschlecht
F
Eingang
10.01.2023
Impfdatum
04.01.2023
Beginn
04.01.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Fatigue Influenza like illness Malaise Pain

Symptomtext

Patient reported getting home after the vaccine and feeling not well. She reports flu like symptoms, feels body aches, and fatigue for the last week since vaccination. I advised the patient that since it would take approximately 2 week to have full immunity after the vaccine, she may have been exposed to the flu virus or another illness before and/or after the vaccine. I suggested she contact her doctor and if she could not get an appointment right away, to seek care at a walk in or urgent care facility.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Fatigue
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none known
Vorgeschichte
Patient states she has asthma
Andere Medikamente
none known
Allergien
none known
Vorherige Impfungen
felt sick after Moderna COVID vaccines

VAERS 2550156

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
SD
Alter
50,0
Geschlecht
F
Eingang
04.01.2023
Impfdatum
31.12.2022
Beginn
31.12.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling

Symptomtext

patient reported redness and swelling at the injection site, with pain running up to the shoulder starting 1/4/23

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2522660

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

mild
Staat
GA
Alter
56,0
Geschlecht
F
Eingang
04.12.2022
Impfdatum
01.12.2022
Beginn
02.12.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pain Injection site swelling Injection site warmth Pain in extremity

Symptomtext

Patient was administered flublok on 12/1 had sore arm that night, noticed redness, swelling and "heat" from injection site. Patient started using cold compresses. Patient presented at pharmacy on 12/4 and showed pharmacy a picture of her arm on 12/1 and her physical arm on 12/4 . Redness and swelling looks better but still tender per patient. Patient has dr's visit on 12/5 in AM.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
n/a
Aktuelle Erkrankungen
n/a
Vorgeschichte
blood pressure
Andere Medikamente
n/a
Allergien
n/a
Vorherige Impfungen
-

VAERS 2497643

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
NY
Alter
30,0
Geschlecht
F
Eingang
03.11.2022
Impfdatum
31.10.2022
Beginn
01.11.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash pruritic

Symptomtext

Discovered itchy rash/spot on left hand after receiving flublok vaccine on 10/31. Applied alcohol and hydrocortisone to help relieve itchiness.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
N/A
Vorgeschichte
N/A
Andere Medikamente
N/A
Allergien
N/A
Vorherige Impfungen
-

VAERS 2496462

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

mild
Staat
FL
Alter
46,0
Geschlecht
F
Eingang
02.11.2022
Impfdatum
02.11.2022
Beginn
02.11.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
Dizziness Throat tightness

Symptomtext

patient stated she felt dizzy and throat tightness. by time patient got back in room, throat no longer felt tight but still felt dizzy. patient did not experience swelling of face or tongue and was able to talk througout whole interaction, so administered benadryl. asked patient if she had anything to eat or drink yet. she said yes. offered crackers and water. she accepted water. monitored bp and hr, was within normal range. observed for 15 minutes in room. counseled pt on s/sx of allergic reaction and to contact 911 if experienced those s/sx at home.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Dizziness
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
penicillin
Vorherige Impfungen
-

VAERS 2489196

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
MO
Alter
13,0
Geschlecht
F
Eingang
25.10.2022
Impfdatum
22.10.2022
Beginn
22.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Contusion Pain in extremity Product administered to patient of inappropriate age

Symptomtext

Patient was given vaccine indicated for people over the age of 18. We contacted patient's mother to notify of error and mother stated daughter had bruised, sore arm also.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
N/A
Aktuelle Erkrankungen
NONE
Vorgeschichte
NONE
Andere Medikamente
UNKNOWN
Allergien
NONE
Vorherige Impfungen
-

VAERS 2484016

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
PA
Alter
64,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
19.10.2022
Beginn
20.10.2022
Tage bis Beginn
1,0
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling Injection site warmth

Symptomtext

Patient received flu shot yesterday morning and reported to us this afternoon that she has red/raised slightly itchy spot where shot was given. Slight hot to touch. Assessed and reccommended to put ice packs on and keep and eye on. To report any changes to HC provider/ED if necessary.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483984

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
NC
Alter
32,0
Geschlecht
F
Eingang
20.10.2022
Impfdatum
11.10.2022
Beginn
11.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus Injection site swelling

Symptomtext

After one hour, patient returned to clinic with swelling, redness, and itching at injection site. We verified that she had received FluBlok because of reported egg allergy history. Patient took Benadryl to help with symptoms.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
Allergy to eggs
Vorherige Impfungen
Fluzone

VAERS 2483516

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

mild
Staat
LA
Alter
15,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Influenza like illness Product administered to patient of inappropriate age Pyrexia

Symptomtext

. patient was administered flublok which is not approved for her age .had high fever and flu like symptoms. dad took her to the dr and gave her tylenol

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pyrexia
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472684

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
TX
Alter
12,0
Geschlecht
M
Eingang
08.10.2022
Impfdatum
08.10.2022
Beginn
08.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Pain in extremity

Symptomtext

Sore arm

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pain in extremity
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
Sore Arm

VAERS 2468830

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

mild
Staat
OK
Alter
61,0
Geschlecht
F
Eingang
04.10.2022
Impfdatum
30.09.2022
Beginn
01.10.2022
Tage bis Beginn
1,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Rash Rash pruritic

Symptomtext

Patient has rash on both arms and chest. She says it just itches a little bit. She has tried taking an antihistamine but rash has not cleared up. She said she will give it a few more days to see if it clears up and will let us know.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
No test have been done yet
Aktuelle Erkrankungen
No
Vorgeschichte
Diabetes
Andere Medikamente
Unknown
Allergien
Penicillin, Lisinopril
Vorherige Impfungen
-

VAERS 2459789

SANOFI PASTEUR · INFLUENZA (SEASONAL) (FLUZONE HIGH-DOSE QUADRIVALENT) · Charge UJ909AA

mild
Staat
TX
Alter
72,0
Geschlecht
F
Eingang
24.09.2022
Impfdatum
21.09.2022
Beginn
22.09.2022
Tage bis Beginn
1,0
Dosis
N/A
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site swelling Skin warm

Symptomtext

Per patient she received the shot on Wednesday 9/21/22 in her right arm. Didn't take a look at it until the next morning and noticed and injection site reaction. Arm was red and swollen about 2 1/2". Reported to pharmacist on duty on Thursday. Let the vaccine administrator know Friday night. Tried to follow up and left voicemail. Patient called back Saturday afternoon. Reported that redness/warmth has spread to about 7". Pt took aleve the night of and then an antihistamine Thursday. Tried cold compress as well. Recommended to follow up with a doctor to be safe, continue with anti-inflammatory and cold compresses.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
none yet
Aktuelle Erkrankungen
NO PER PATIENT
Vorgeschichte
NO PER PATIENT
Andere Medikamente
CALCIUM +VITAMIN D. TERBINAFINE
Allergien
STRONG REACTION TO DEMEROL.
Vorherige Impfungen
-

VAERS 2519684

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ909AA

gering
Staat
MS
Alter
14,0
Geschlecht
F
Eingang
30.11.2022
Impfdatum
19.11.2022
Beginn
19.11.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
No adverse event Product administered to patient of inappropriate age

Symptomtext

given to a patient under 18 years of age with no reported adverse event; Initial information was received on 21-Nov-2022 regarding an unsolicited valid non-serious case received from a other health professional. This case involves a 14 years old female patient who had given to a patient under 18 years of age with no reported adverse event after receiving influenza quadrivalent recombinant vaccine [Flublok]. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. At the time of the event, the patient had ongoing Egg allergy. On 19-Nov-2022, the patient received 0.5 ml dose of suspect influenza quadrivalent recombinant vaccine (unknown formulation) (Frequency: once) (with lot: UJ909AA, expiry date: 30-Jun-2023) (strength was unknown) via intramuscular route in left deltoid site for Immunization. On 19-Nov-2022 the patient had a non-serious event given to a patient under 18 years of age with no reported adverse event (Product administered to patient of inappropriate age) (latency: same day) following the administration of influenza quadrivalent recombinant vaccine. Action taken: not applicable. It was not reported if the patient received a corrective treatment for the event. At time of reporting, the outcome was Recovered / Resolved in 2022 for the event. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Egg allergy
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2494684

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK) · Charge UJ909AA

gering
Staat
MO
Alter
13,0
Geschlecht
F
Eingang
01.11.2022
Impfdatum
22.10.2022
Beginn
22.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
OT / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

administration of FLUBLOK to a pediatric patient with no reported adverse event; Initial information received on 24-Oct-2022 regarding an unsolicited valid non-serious case received from a pharmacist. This case involves a 13 years old female patient and there was administration of flublok (INFLUENZA QUADRIVALENT RECOMBINANT VACCINE) to a pediatric patient with no reported adverse event. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 22-Oct-2022, the patient received a dose of 0.5 ml of suspect INFLUENZA QUADRIVALENT RECOMBINANT VACCINE (formulation, strength: unknown) lot UJ909AA, expiration date: 30-Jun-2023 via intramuscular route in the left deltoid as Immunization. On 22-OCT-2022 there was an administration of flublok to a pediatric patient with no reported adverse event (product administered to patient of inappropriate age) same day following the administration of INFLUENZA QUADRIVALENT RECOMBINANT VACCINE. Action taken was not applicable. It was not reported if the patient received a corrective treatment for the event (administration of FLUBLOK to a pediatric patient with no reported adverse event). At time of reporting, the outcome was Unknown for the event This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2487482

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
MO
Alter
63,0
Geschlecht
F
Eingang
24.10.2022
Impfdatum
08.10.2022
Beginn
15.10.2022
Tage bis Beginn
7,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Tongue blistering

Symptomtext

Patient states approximately one to two weeks after receiving her Covid bivalent Pfizer booster she developed several tiny white blisters on her tongue.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Tongue blistering
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2486617

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
AR
Alter
17,0
Geschlecht
F
Eingang
23.10.2022
Impfdatum
22.10.2022
Beginn
22.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Vaccine was given to minor by mistake when vaccine is indicated for 18 years and older. Patient feels fine today 10/23 (24 hours later), but wanted reported in case of issues.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none
Vorgeschichte
none listed
Andere Medikamente
none
Allergien
none known of
Vorherige Impfungen
-

VAERS 2486415

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
MS
Alter
12,0
Geschlecht
M
Eingang
22.10.2022
Impfdatum
22.10.2022
Beginn
22.10.2022
Tage bis Beginn
0,0
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Recognized Flublok inadvertently given to patient under 18 years of age. No side effects noted per mom

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483521

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

gering
Staat
LA
Alter
11,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

patient was administered flublok which is not approved for her age

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2483520

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge uj909aa

gering
Staat
LA
Alter
13,0
Geschlecht
F
Eingang
19.10.2022
Impfdatum
01.10.2022
Beginn
01.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

patient was administered flublok which is not approved for her age

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2481680

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
MA
Alter
77,0
Geschlecht
F
Eingang
18.10.2022
Impfdatum
06.10.2022
Beginn
01.10.2022
Tage bis Beginn
-
Dosis
UNK
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt
No adverse event Product administered to patient of inappropriate age

Symptomtext

Flublock to be administered to people 18 years old - 64 year old's. This client is 77, with no reported effects from vaccination. This client has given NO report of any adverse effect at this time.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
unknown
Vorgeschichte
unknown
Andere Medikamente
unknown
Allergien
unknown
Vorherige Impfungen
-

VAERS 2480547

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
MO
Alter
13,0
Geschlecht
F
Eingang
17.10.2022
Impfdatum
14.10.2022
Beginn
14.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Product administered to patient of inappropriate age

Symptomtext

Flublok given to patient under the age of 8

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
none
Vorgeschichte
none
Andere Medikamente
none
Allergien
none
Vorherige Impfungen
-

VAERS 2475818

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
IA
Alter
57,0
Geschlecht
F
Eingang
11.10.2022
Impfdatum
11.10.2022
Beginn
11.10.2022
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
IM / RA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Extra dose administered

Symptomtext

Pt came in for yearly flu and Pfizer bivalent immunization; dose administered; pt called back asking to talk with pharmacy as she had received flu shot at physician's office 09/14/2022;

Weitere VAERSDATA-Felder
Praegender Schweregrund
Extra dose administered
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2472688

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909aa

gering
Staat
TX
Alter
13,0
Geschlecht
F
Eingang
08.10.2022
Impfdatum
08.10.2022
Beginn
08.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Product administered to patient of inappropriate age

Symptomtext

Mother unable to be reached at time of discovery

Weitere VAERSDATA-Felder
Praegender Schweregrund
Product administered to patient of inappropriate age
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-

VAERS 2470293

PROTEIN SCIENCES CORPORATION · INFLUENZA (SEASONAL) (FLUBLOK QUADRIVALENT) · Charge UJ909AA

gering
Staat
ME
Alter
64,0
Geschlecht
F
Eingang
05.10.2022
Impfdatum
05.10.2022
Beginn
05.10.2022
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Induration Mass Swelling

Symptomtext

Immediate swelling, hard lump about the size of a golf ball

Weitere VAERSDATA-Felder
Praegender Schweregrund
Induration
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
none noted
Vorgeschichte
none noted
Andere Medikamente
none known
Allergien
prednisone
Vorherige Impfungen
-